Holen Sie sich die Stockscreener-App
199.71
2.64%
-5.42
Handel nachbörslich:
198.64
-1.07
-0.54%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$205.13
Offen:
$205.55
24-Stunden-Volumen:
5.17M
Relative Volume:
2.12
Marktkapitalisierung:
$47.45B
Einnahmen:
$234.31B
Nettoeinkommen (Verlust:
$1.61B
KGV:
30.15
EPS:
6.6243
Netto-Cashflow:
$4.45B
1W Leistung:
-6.30%
1M Leistung:
+4.99%
6M Leistung:
+28.45%
1J Leistung:
+62.01%
1-Tages-Spanne:
$198.75
$206.70
1-Wochen-Bereich:
$198.75
$214.07
52-Wochen-Spanne:
$114.60
$214.93
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
199.71 | 48.74B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
805.37 | 102.41B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
335.31 | 68.03B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
72.88 | 8.44B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.39 | 790.85M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Key facts: Cardinal Health prioritizes high ROI; officers surrender shares - TradingView
Will Cardinal Health Inc. stock maintain strong growth2025 Trading Volume Trends & Weekly Top Gainers Alerts - Newser
What Recent Specialty Pharma Moves Mean for Cardinal Health’s Stock Valuation - simplywall.st
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve - Nasdaq
Intrauterine Pressure Catheter Market Outlook Report 2032 | - openPR.com
Cardinal Health Insiders Sell US$51m Of Stock, Possibly Signalling Caution - Yahoo Finance
Cardinal Health Inc Stock Analysis and ForecastHealthcare Stock Analysis & Outstanding Investment Trading - earlytimes.in
Shorts Report: How Cardinal Health Inc. stock moves in volatile trading sessions2025 Market Trends & Real-Time Buy Signal Notifications - BỘ NỘI VỤ
Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know - Yahoo Finance
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views? - Finviz
Will Cardinal Health Inc. stock recover faster than industryQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Healthcare earnings top S&P 500 behind drug, hospital demand - Modern Healthcare
Is Cardinal Health’s Rally Justified After Major Contract Wins in 2025? - Yahoo Finance
Cardinal Health’s Sales And Profits Outpaced Wall Street Forecasts - Finimize
Cardinal Health (CAH): Exploring Valuation Following a 30% Share Price Surge - simplywall.st
Cardinal Health (NYSE:CAH) Shareholders Have Earned a 34% CAGR Over the Last Five Years - 富途牛牛
InnerActiv Adds Former Cardinal Health CEO Mike Kaufmann to Board, Former NSA Ops Director Jon Darby as - EIN News
InnerActiv Adds Former Cardinal Health CEO Mike Kaufmann to Board, Former NSA Ops Director Jon Darby as Advisor - Louisiana First News
Cardinal Health Lifts Outlook After Specialty Drug Sales Jump - Finimize
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
A Look at Cardinal Health’s Valuation Following Strong Q3 Earnings and Renewed Growth Optimism - Yahoo Finance
What dividend safety score for Cardinal Health Inc. stockPortfolio Gains Report & Risk Managed Investment Strategies - newser.com
Did Cardinal Health’s (CAH) Earnings Beat and Japan Expansion Just Shift Its Growth Narrative? - Sahm
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - MSN
Can Cardinal Health Inc. (CLH) stock sustain institutional flowsWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Why Cardinal Health Inc. (CLH) stock could be next leaderChart Signals & Weekly High Return Stock Opportunities - newser.com
Why ETFs are accumulating Cardinal Health Inc. (CLH) stockWeekly Loss Report & Fast Exit and Entry Trade Guides - newser.com
Can Cardinal Health Inc. stock sustain institutional flowsTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Trend analysis for Cardinal Health Inc. this weekJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
Can Cardinal Health Inc. stock ride next bull market cycle2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Can Cardinal Health Inc. (CLH) stock sustain double digit ROEJuly 2025 Outlook & AI Enhanced Trading Signals - newser.com
Cardinal Health stock hits all-time high at 208.34 USD By Investing.com - Investing.com Canada
Why millennials buy Cardinal Health Inc. (CLH) stock2025 Macro Impact & Free Fast Entry Momentum Trade Alerts - newser.com
Is Cardinal Health Inc. stock testing key support2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Using R and stats models for Cardinal Health Inc. forecastingMarket Volume Summary & Stock Portfolio Risk Management - newser.com
How Cardinal Health Inc. stock benefits from global expansionJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Can Cardinal Health Inc. stock hit consensus price targetsQuarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Is Cardinal Health Inc. (CLH) stock expanding market penetrationJuly 2025 Volume & Low Drawdown Investment Ideas - newser.com
6 Healthcare Stocks With Strong Upward Momentum - Benzinga
Cardinal Health Stock (CAH) Opinions on Recent Stock High and Market Expansion - Quiver Quantitative
Deutsche Bank Raises Price Target on Cardinal Health to $208 From $195, Keeps Hold Rating - MarketScreener
Volatility clustering patterns for Cardinal Health Inc.Share Buyback & Verified Entry Point Detection - newser.com
Cardinal Health Inc. (CAH) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Is a relief rally coming for Cardinal Health Inc. holdersWeekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Leerink Partners Adjusts PT on Cardinal Health to $230 From $211, Maintains Outperform Rating - MarketScreener
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):